Thomas King Appointed to LEERINK Partners LLC Board

09:30 EDT 29 Jun 2017 | Businesswire

Leerink Holdings LLC, the parent company of LEERINK Partners, a leading healthcare investment bank, announced today the appointment of Thomas King to its Board.

Mr. King has more than 25 years of experience in the investment banking and financial services industry, having advised on over 100 publicly announced M&A transactions and numerous capital raisings for major corporate, private equity and government clients globally.

Most recently Mr. King served as Chief Executive Officer of Investment Banking at Barclays and Chairman of the Investment Banking Executive Committee. Mr. King was also a member of the Barclays Group Executive Committee.

Mr. King began his career at Salomon Brothers, which was later acquired by Citigroup. During his tenure at Citi, Mr. King held several senior roles, including Global Head of Mergers and Acquisitions, Head of Investment Banking for the EMEA (Europe, Middle East and Africa) Region and Head of Corporate and Investment Banking for the EMEA region.

In 2009, Mr. King moved to Barclays as the Head of European Investment Banking and Co-Head of Global Corporate Finance. He was later promoted to Global Head of Investment Banking and eventually to CEO of the Investment Bank. In response to the financial crisis and changing regulation and prior to his retirement from management in 2016, Mr. King led a major restructuring of the Investment Bank.

“We are thrilled to have Tom join the Board,” said Jeff Leerink, Chairman and CEO of LEERINK Partners. “His breadth of relevant industry experience, including advising some of the world’s largest companies through complex and transformational transactions and leading global investment banking efforts, makes Tom an invaluable addition to our team as we continue to advance the firm.”

Mr. King added, “In a dynamic banking market and changing healthcare environment, LEERINK Partners is incredibly well-positioned to advise leading healthcare companies and emerging entrepreneurs on their next phase of growth. I look forward to joining the Board and partnering with Jeff, the Board and the entire LEERINK Partners’ talented team to develop strategies that deliver value to clients and shape the future direction of the firm and the healthcare industry.”

About LEERINK Partners

Leerink Holdings LLC is the parent company of LEERINK Partners LLC and Leerink Capital Partners.

LEERINK Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. LEERINK Partners LLC is a member of FINRA/SIPC. For more information, please visit:

LEERINK Partners
Marissa Devnew, 617-918-4030
Weber Shandwick
Kaitlyn Rawlett, 212-445-8082


More From BioPortfolio on "Thomas King Appointed to LEERINK Partners LLC Board"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.